The QCI Interpret platform is a software platform developed for clinical genetic testing and biomarker analysis. This tool is designed to assist healthcare professionals in interpreting genetic data, reporting, and clinical decision-making processes. It is commonly used in the evaluation of data related to cancer, hereditary diseases, and other genetic conditions. QCI Interpret provides a detailed analysis of clinical variants and classifies genetic variants according to ACMG (American College of Medical Genetics) guidelines. Clinically significant variants are evaluated in categories such as pathogenicity, benignity, and likely benign. It is highly useful in the fields of oncology, hereditary diseases, and rare diseases with advanced variant interpretation features. In somatic analyses, it provides prognostic evaluations and offers insights into the possible course of diseases. It allows the integration of data obtained from different genetic tests. With a user-friendly interface, it reports genetic test results in an understandable way. It offers tools for identifying specific biomarkers and evaluating their clinical significance. It conducts a comprehensive literature review to provide up-to-date information on genetic variations. It helps develop individualized treatment approaches based on genetic test results.